Editorial Recommendations of the Month

Key articles from high impact journals in last month

August 2021

Ustekinumab 90 mg Every 2 Weeks for the Treatment of Inflammatory Bowel Disease

Storan D, Doherty GA, Cullen G

Published Jul 2021, in the Clinical gastroenterology and hepatology

Assessment of Vedolizumab Disease-Drug-Drug Interaction Potential in Patients With Inflammatory Bowel Diseases

Sun W, Lirio RA, Schneider J, Aubrecht J, Kadali H, Baratta M, Gulati P, Suri A, Lin T, Vasudevan R, Rosario M

Published Jul 2021, in the Clinical Pharmacology in Drug Development

Mental Health Factors Associated With Fatigue in Mexican Patients With Inflammatory Bowel Disease

Fresán Orellana A, Parra Holguín NN, Yamamoto-Furusho JK

Published Aug 2021, in the Journal of clinical gastroenterology.

Diet supporting therapy for inflammatory bowel diseases

Kikut J, Konecka N, Ziętek M, Kulpa D, Szczuko M

Published Aug 2021, in the European journal of nutrition.

Effect of inflammatory bowel disease and related medications on COVID-19 incidence, disease severity, and outcome: the Israeli experience

Richter V, Bermont A, Cohen DL, Broide E, Shirin H

Published Jun 2021, in the European journal of gastroenterology & hepatology

Outcomes of Tofacitinib Dose Reduction in Patients with Ulcerative Colitis in Stable Remission from the Randomised RIVETING Trial

Vermeire S, Su C, Lawendy N, Kobayashi T, Sandborn WJ, Rubin DT, Modesto I, Gardiner S, Kulisek N, Zhang H, Wang W, Panés J

Published Jul 2021, in the Journal of Crohn's & colitis.

Approach to the Management of Recently Diagnosed Inflammatory Bowel Disease Patients: A User's Guide for Adult and Pediatric Gastroenterologists

Macaluso FS, Liguori G, Galli M.

Published Jul 2021, in the Gastroenterology.

Dual Targeted Therapy for the Management of Inflammatory Bowel Disease

Haider M, Lashner B

Published Jul 2021, in the Journal of clinical gastroenterology

Antibiotic use differentially affects the risk of antidrug antibody formation during anti-TNFα therapy in inflammatory bowel disease patients: a report from the epi-IIRN

Yuri Gorelik ,Shay Freilich, Shiran Gerassy-Vainberg, Sigal Pressman, Chagit Friss, Alexandera Blatt, Gili Focht, Yiska Loewenberg Weisband, Shira Greenfeld, Revital Kariv, Nathan Lederman, Iris Dotan, Naama Geva-Zatorsky, Yechezkel Kashi, Shai Shlomo Shen-Orr, Yehuda Chowers, On behalf of the IIRN